Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19

The coronavirus disease 2019 (COVID-19) pandemic caused by the emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health, and there is an urgent need to develop safe and effective vaccines. Here, we report the generation and the preclinical evaluation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Capone, Stefania, Raggioli, Angelo, Gentile, Michela, Battella, Simone, Lahm, Armin, Sommella, Andrea, Contino, Alessandra Maria, Urbanowicz, Richard A., Scala, Romina, Barra, Federica, Leuzzi, Adriano, Lilli, Eleonora, Miselli, Giuseppina, Noto, Alessia, Ferraiuolo, Maria, Talotta, Francesco, Tsoleridis, Theocharis, Castilletti, Concetta, Matusali, Giulia, Colavita, Francesca, Lapa, Daniele, Meschi, Silvia, Capobianchi, Maria, Soriani, Marco, Folgori, Antonella, Ball, Jonathan K., Colloca, Stefano, Vitelli, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062434/
https://www.ncbi.nlm.nih.gov/pubmed/33895322
http://dx.doi.org/10.1016/j.ymthe.2021.04.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062434/
https://www.ncbi.nlm.nih.gov/pubmed/33895322
http://dx.doi.org/10.1016/j.ymthe.2021.04.022

Ejemplares similares